Posts Tagged ‘Evergreen Treatment Services’

Ron Jackson, Executive Director of Evergreen Treatment Services, Retires

January 18, 2013
Newly retired Mr. Jackson has plans to take up the ukelele and travel to Hawaii as much as possible!

Ron has plans to take up the ukelele and travel to Hawaii!

After 33 years as the Executive Director of Evergreen Treatment Services, a long-time CTP in the Pacific Northwest Node of the CTN, Ron Jackson, MSW, LICSW, officially retired from that position on January 13, 2013.

He will continue in a part-time role at ETS, helping with the REACH Program, which includes the Law Enforcement Assisted Diversion (LEAD) Project and with the potential establishment of new clinics.  Ron will also retain his faculty position at the University of Washington’s School of Social Work. Over many years, Ron collaborated with UW researchers on numerous projects, most recently on NIDA’s National Drug Treatment Clinical Trials Network (CTN) where he represented community treatment programs on the CTN Executive Committee.

Ron’s successor at ETS is Molly Carney, PhD.  Dr. Carney received her doctorate in Clinical Psychology from the University of Washington and worked in Alan Marlatt’s Addictive Behaviors Research Center before moving to the UW Alcohol and Drug Abuse Institute.  She left ADAI in 2006 to complete her MBA at the UW Foster School of Business in 2007.  Last year, Dr. Carney came to work with Ron at ETS where they’ve spent the past 18 months together preparing for this transition.

A retirement party for Ron was held on Friday, January 11th and featured dozens of his staff and colleagues, past and present, many of whom gave brief speeches praising Ron’s professionalism, dedication to service, and decades of hard work balanced with a generous and good-natured spirit.

A set of wonderful photographs from this event, taken by photographer Jarett Kaplan, can be found at this URL: https://picasaweb.google.com/104124588174141071416/RonJacksonRetirementParty1112013?authuser=0&authkey=Gv1sRgCJ33uYPIz6XrYg&feat=directlink

Best of luck to you, Mr. Jackson, in this new chapter of your life! We will miss you very much here at ADAI!

 

Beyond Drug Use: Other Outcomes in Treatment Evaluation

November 3, 2011

Ron Jackson, MSW, director of the Pacific Northwest Node community treatment program Evergreen Treatment Services, recently served on a panel of substance abuse treatment and research experts convened by NIDA to discuss appropriate outcome measures for clinical trials of substance abuse treatments.

Across the addictions field, the primary outcome in treatment research has been reduction in drug consumption. Despite a compelling rationale for moving beyond drug use as the sole standard for evaluating addiction treatment, the field has yet to adopt any core set of other measures that are routinely incorporated into treatment research.

This report from the panel, currently in-press in Addiction, provides an overview of previous recommendations and outlines specific guidelines for consideration of candidate outcomes. A list of outcomes meeting those guidelines is described with two strongly recommended for inclusion: craving and quality of life. The paper ends with ideas on how to move ahead with incorporating these outcomes into treatment research.

Citation: Tiffany ST, Friedman L, Greenfield SF, Hasin DS, Jackson R. Beyond Drug Use: A Systematic Consideration of Other Outcomes in Evaluations of Treatments for Substance Use Disorders. Addiction 2011 (in press). doi: 10.1111/j.1360-0443.2011.03581.x

PN Node Authors in JSAT’s Special Supplement: A Decade of Research in the CTN

March 30, 2010

In honor of the CTN’s 10th anniversary, the Journal of Substance Abuse Treatment presents “A Decade of Research by the National Drug Abuse Treatment Clinical Trials Network.”

This special supplement features overview articles describing the completed studies and outcomes from the past decade of CTN research. It also reviews several ancillary investigations, where data from original CTN protocols is examined in a new way to reveal new correlations and propose future research.

Five articles in the issue are co-authored by researchers and clinicians from the Pacific Northwest node:

Ron Jackson, from Evergreen Treatment Services, cowrote “The First Decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap Between Research and Practice to Improve Drug Abuse Treatment,” which reviews the rationale for the CTN, describes the translation of its guiding principles into research endeavors, and anticipates the future evolution of clinical research within the Network.

In “Study Results from the Clinical Trial Network’s First 10 Years: Where Do They Lead?Elizabeth (Betsy) Wells, Don Calsyn and Dennis Donovan from ADAI, Andrew Saxon from the VA Puget Sound, and Ron Jackson from Evergreen Treatment Services, review the completed (to date) protocols in the CTN with the aim of identifying the incremental progress toward improving drug treatment made by these trials.

From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network,” was co-written by Andrew Saxon of the VA Puget Sound, and reviews the 6 CTN  buprenorphine protocols (CTN-0001/2, 0003, 0010, 0027, 0030), describing related efforts to overcome challenges to the implementation of buprenorphine therapy in mainstream practice.

Jessica DiCenzo from Recovery Centers of King County, a PN Node CTP, was co-author for “Predicting Outpatient Treatment Entry Following Detoxification for Injection Drug Use: The Impact of Patient and Program Factors.”  This secondary analysis of data from CTN-0017  examined variables predicting outpatient treatment entry within six months of residential detoxification.

And finally, Don Calsyn from ADAI co-authored “Multisite Effectiveness Trials of Treatments for Substance Abuse and Co-Occurring Problems: Have We Chosen the Best Designs?”  This article systematically examines, for each of the completed CTN protocols, the experimental design type chosen and its original rationale, the main findings of the trials, and the strengths and weaknesses of the design in hindsight.

Congratulations to all our Pacific Northwest Node authors!

Find these articles and all the others from the JSAT special supplement in the CTN Dissemination Library.